Cargando…
Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells
The effective antitumor drug evodiamine (EVO) is attracting increased attention. Therefore, the present study aimed to investigate the effects of EVO on the proliferation, apoptosis and autophagy of human pancreatic cancer (PC) cell lines in vitro and in vivo. Human PANC-1 and SW1990 PC cell lines w...
Autores principales: | Hong, Zhong, Wang, Zhaohong, Zhou, Bin, Wang, Jisheng, Tong, Hongfei, Liao, Yi, Zheng, Peng, Jamshed, Muhammad Babar, Zhang, Qiyu, Chen, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010218/ https://www.ncbi.nlm.nih.gov/pubmed/31922213 http://dx.doi.org/10.3892/ijo.2020.4956 |
Ejemplares similares
-
Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma
por: Wang, Rong, et al.
Publicado: (2018) -
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
por: Wei, Wei-Tian, et al.
Publicado: (2011) -
The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
por: Du, Juan, et al.
Publicado: (2016) -
Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005) -
Upregulation of SIRT1 by Evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration
por: Kuai, Jianbo, et al.
Publicado: (2022)